BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9303061)

  • 1. Musculoskeletal complications of neutron therapy for prostate cancer.
    Soulen RL; Romero JA; Chuba PJ; Evelhoch JL; Simpson RE; Forman JD
    Radiat Oncol Investig; 1997; 5(2):81-91. PubMed ID: 9303061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient self-assessment of complications and quality of life after conformal neutron and photon irradiation for localized prostate cancer.
    Reddy SM; Ruby J; Wallace M; Forman JD
    Radiat Oncol Investig; 1997; 5(5):252-6. PubMed ID: 9372548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of magnetic resonance imaging and physical examination findings in patients with greater trochanteric pain syndrome.
    Bird PA; Oakley SP; Shnier R; Kirkham BW
    Arthritis Rheum; 2001 Sep; 44(9):2138-45. PubMed ID: 11592379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
    Kupelian P; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A; Kuban D
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):795-9. PubMed ID: 15925452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
    Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study.
    Zapatero A; Valcárcel F; Calvo FA; Algás R; Béjar A; Maldonado J; Villá S
    J Clin Oncol; 2005 Sep; 23(27):6561-8. PubMed ID: 16170164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model for quantitative changes in the magnetic resonance parameters of muscle in children after therapeutic irradiation.
    Krasin MJ; Xiong X; Reddick WE; Ogg RJ; Hoffer FA; McCarville B; Kaste SC; Spunt SL; Navid F; Davidoff AM; Zhang L; Kun LE; Merchant TE
    Magn Reson Imaging; 2006 Dec; 24(10):1319-24. PubMed ID: 17145403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.
    Martinez AA; Demanes DJ; Galalae R; Vargas C; Bertermann H; Rodriguez R; Gustafson G; Altieri G; Gonzalez J
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1322-31. PubMed ID: 16029788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between baseline femoral neck marrow status and the development of femoral head osteonecrosis in corticosteroid-treated patients: a longitudinal study by MR imaging.
    Vande Berg BC; Gilon R; Malghem J; Lecouvet F; Depresseux G; Houssiau FA
    Eur J Radiol; 2006 Jun; 58(3):444-9. PubMed ID: 16510260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of modest dose irradiation in combination with long-term endocrinal treatment for high-risk prostate cancer: a preliminary report.
    Sasaki T; Nakamura K; Shioyama Y; Ohga S; Urashima Y; Terashima H; Koga H; Naito S; Noma H; Komatsu K; Yamaguchi A; Honda H
    Jpn J Clin Oncol; 2004 Jul; 34(7):420-4. PubMed ID: 15342670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer.
    Bayley AJ; Catton CN; Haycocks T; Kelly V; Alasti H; Bristow R; Catton P; Crook J; Gospodarowicz MK; McLean M; Milosevic M; Warde P
    Radiother Oncol; 2004 Jan; 70(1):37-44. PubMed ID: 15036850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
    Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
    J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI of joint fluid in femoral head osteonecrosis.
    Chan WP; Liu YJ; Huang GS; Jiang CC; Huang S; Chang YC
    Skeletal Radiol; 2002 Nov; 31(11):624-30. PubMed ID: 12395273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymptomatic avascular osteonecrosis of the hip in new patients diagnosed as systemic lupus erythematosus in Ramathibodi Hospital.
    Jaovisidha S; Denprechawong R; Suwannalai P; Janwityanujit S
    J Med Assoc Thai; 2007 Jul; 90(7):1382-90. PubMed ID: 17710981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical response after 3-d conformal radiotherapy of localized prostate cancer to a total dose of 66 gy 4-year results.
    Wachter-Gerstner N; Wachter S; Goldner G; Nechvile E; Pötter R
    Strahlenther Onkol; 2002 Oct; 178(10):542-7. PubMed ID: 12386785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-treatment complications of soft tissue tumours.
    Shapeero LG; De Visschere PJ; Verstraete KL; Poffyn B; Forsyth R; Sys G; Uyttendaele D
    Eur J Radiol; 2009 Feb; 69(2):209-21. PubMed ID: 19101106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
    Kupelian P; Kuban D; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):415-9. PubMed ID: 15667961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of MR imaging in the detection of hip involvement in patients with ankylosing spondylitis.
    Huang ZG; Zhang XZ; Hong W; Wang GC; Zhou HQ; Lu X; Wang W
    Eur J Radiol; 2013 Sep; 82(9):1487-93. PubMed ID: 23680154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer.
    Jo Y; Hiratsuka J; Fujii T; Takenaka A; Fujisawa M
    Urology; 2004 Sep; 64(3):556-60. PubMed ID: 15351592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.